ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 74 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,000 | -46.7% | 2,815 | -26.6% | 0.00% | – |
| Q4 2019 | $15,000 | -25.0% | 3,835 | 0.0% | 0.00% | – |
| Q3 2019 | $20,000 | -16.7% | 3,835 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -20.0% | 3,835 | -9.6% | 0.00% | – |
| Q1 2019 | $30,000 | -3.2% | 4,243 | +15.3% | 0.00% | – |
| Q4 2018 | $31,000 | -57.5% | 3,679 | 0.0% | 0.00% | – |
| Q3 2018 | $73,000 | -23.2% | 3,679 | 0.0% | 0.00% | – |
| Q2 2018 | $95,000 | +28.4% | 3,679 | +19.2% | 0.00% | – |
| Q1 2018 | $74,000 | -43.9% | 3,087 | -19.7% | 0.00% | – |
| Q4 2017 | $132,000 | +41.9% | 3,845 | -13.7% | 0.00% | – |
| Q3 2017 | $93,000 | +50.0% | 4,457 | +25.7% | 0.00% | – |
| Q2 2017 | $62,000 | -15.1% | 3,546 | -15.7% | 0.00% | – |
| Q1 2017 | $73,000 | 0.0% | 4,208 | -1.0% | 0.00% | – |
| Q4 2016 | $73,000 | +170.4% | 4,250 | +150.7% | 0.00% | – |
| Q3 2016 | $27,000 | +3.8% | 1,695 | 0.0% | 0.00% | – |
| Q2 2016 | $26,000 | +8.3% | 1,695 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | – | 1,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,474,482 | $38,661,000 | 18.12% |
| GREAT POINT PARTNERS LLC | 772,600 | $20,258,000 | 7.90% |
| BOW STREET LLC | 126,870 | $3,327,000 | 1.61% |
| Opaleye Management Inc. | 150,000 | $3,933,000 | 1.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 316,690 | $8,304,000 | 0.64% |
| WALL STREET ASSOCIATES | 225,000 | $5,899,000 | 0.56% |
| Granite Point Capital Management, L.P. | 61,813 | $1,621,000 | 0.47% |
| EMERALD ADVISERS, LLC | 348,721 | $9,143,000 | 0.44% |
| TFS CAPITAL LLC | 97,652 | $2,560,000 | 0.25% |
| Spark Investment Management LLC | 59,300 | $1,553,000 | 0.22% |